• 主题
高级搜索  >
历史搜索 清空历史
首页> 美国政府科技报告 >Effects of rhCC10 as a Post-Treatment in Mice Challenged with Phosgene
【24h】

Effects of rhCC10 as a Post-Treatment in Mice Challenged with Phosgene

机译：rhCC10作为后处理对光气攻击小鼠的影响

获取原文
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

In this study we evaluated the therapeutic efficacy of a post- exposure administration of rhCC10 (Claragen, Inc., Rockville, MD) against a toxic concentration of phosgene. rhCC10 0 is described as a 1 10kDa Clara Cell protein, an anti-inflammatory lung protein that is present on all mammalian mucosal surfaces. It protects against infection and environmental pollutants but apparently not against phosgene, which has a substantial effect in bronchioles and permeability in the deep alveolar lung. Supplementation with rhCC10 did not increase survival of animals exposed to phosgene compared with those treated with saline alone. In addition, the results of the bioassays show no significant differences between saline and the rhCC10 doses; therefore, there has not been any determination of rhCC10 as a beneficial post-exposure therapy for phosgene.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号